2024-03-29, Fri.

Top Stories       Business       Culture & Life       Science & Technology       World

Lecture

Notification

 

NEWS > Science & Technology


JSR Life Sciences Announces Operational Consolidation of KBI Biopharma, Inc. and Selexis SA to Operate as one Organization, Providing Seamless Experie

KBI¡¯s new model will enhance operational efficiencies, drive strategic clarity, and accelerate innovation for global biopharma customers
Date: 2023-06-01

SUNNYVALE, CALIF.-- June 01, 2023 -- JSR Life Sciences today announced that KBI Biopharma, Inc. (KBI) and Selexis SA are consolidating as one organization under the KBI Biopharma name to accelerate innovation and growth for its global biopharma customers. The new structure will enable integrated, seamless solutions for customers, cell line development through process development, to clinical and commercial cGMP manufacturing services for mammalian programs.

The streamlined operational approach supports customers in rapidly accelerating drug development and manufacturing, creating greater flexibility, efficiencies, and a simplified partner experience. By bringing together the capabilities and expertise of KBI Biopharma and Selexis, customers can reduce manufacturing risks and deliver essential medicines to patients faster.

“The fusion of KBI and Selexis as one business advances KBI into an exciting strategic growth phase,” said Tim Lowery, President of JSR Life Sciences. “This natural operational strategy shift is pivotal for KBI and Selexis customers that count on the wide range of capabilities and services to accelerate their evolving manufacturing and drug development needs.”

The combined organization will leverage the collective knowledge, scientific expertise, and industry-leading technical acumen of KBI as an important part of the entire JSR Life Sciences ecosystem. It allows KBI to be a cutting-edge partner for biopharma companies across the globe, propelling KBI forward in becoming a next-generation CDMO. Reorganizing and simplifying the operating model to offer a seamless experience expedites innovation for KBI’s global clients, setting them on a strong forward path.

“The operational consolidation of these two exceptional companies represents a major shift in how KBI Biopharma will operate moving forward,” said J.D. Mowery, Chief Executive Officer of KBI Biopharma. “By providing fully integrated solutions for our customers, we will be a stronger partner that can help them each reach their goals more efficiently.”

Selexis’ proprietary cell line development platform will be branded as the SUREtechnology Platform. Mowery will continue to lead as CEO of the combined organization. Employees will report to the KBI executive team in its entirety.



 to the Top List of News

Notice of Commencement of Operation of Dexerials Photonics Solutions Corporation as Integrated Company Leading Growth in the Photonics Domain
Alphawave Semi and InnoLight Collaborate to Demonstrate Low Latency Linear Pluggable Optics with PCIe 6.0 Subsystem Solution for High-Performance AI
Medisca Opens MAZ Lab in Arizona: An Innovation and Customer Resource Center
Quectel and The Things Industries Announce Partnership to Boost Module Service Management Through LoRaWAN Integration
Efinix Rolls Out Line of FPGAs to Accelerate and Adapt Automotive Designs and Applications
StarFive¡¯s RISC-V Based JH-7110 Intelligent Vision Processing Platform Adopted VeriSilicon¡¯s Display Processor IP
Uniphore Unveils Enhanced Interaction Analytics Solution Powered by Generative AI

 

Laserfiche Announces 2024 Run Smarter Award Winners
LambdaTest and Inflectra Partner to Offer Enhanced Application Lifecyc...
The LYCRA Company joins Performance Days seminar on textile recycling
New Oracle Database Survey Shows Customers Satisfied with Current Rele...
Toshiba Adds New Position Estimation Control Technology to Its Motor C...
Cielo Debuts First Generative AI for Talent Acquisition: CLO.ai
Ventiva Announces Partnership with Clarion for Mass Production of ICE ...
FPT Software Expands Presence in South Korea With Daegu Office Launch
Quectel IoT Modules Significantly More Secure Than Industry Average Ac...
Kymeta Begins Fulfilling Customer Orders of its First Multi-Orbit, On-...

 

 

60, Gamasanro 27gil, Guro-gu, Seoul, Korea, e-mail: news@newsji.com

Copyright, NEWSJI NETWORK.